ANGPT1 and focal segmental glomerulosclerosis: Ang 1–7 infusion accelerates kidney injury in experimental type 1 diabetes [14], worsens kidney damage following unilateral ureteral obstruction (UUO) [16, 17], and has no beneficial renal effects in a model of focal segmental glomerulosclerosis [18].